International Journal of Cancer Management

Published by: Kowsar

No Association Between Human Papillomavirus and Prostate Cancer

Noshin Abdolmaleki 1 , 2 , Mazaher Khodabandehloo 2 , 3 , * , Rashid Ramezanzadeh 2 , 3 and Daem Roshani 4
Authors Information
1 Students Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran
2 Department of Microbiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
3 Cellular & Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
4 Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
Article information
  • International Journal of Cancer Management: April 2018, 11 (4); e10049
  • Published Online: April 30, 2018
  • Article Type: Research Article
  • Received: December 15, 2016
  • Revised: August 30, 2017
  • Accepted: April 8, 2018
  • DOI: 10.5812/ijcm.10049

To Cite: Abdolmaleki N, Khodabandehloo M, Ramezanzadeh R, Roshani D. No Association Between Human Papillomavirus and Prostate Cancer, Int J Cancer Manag. 2018 ; 11(4):e10049. doi: 10.5812/ijcm.10049.

Abstract
Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Bae JM. Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis. Epidemiol Health. 2015;37. e2015005. doi: 10.4178/epih/e2015005. [PubMed: 25687950].
  • 2. Ghasemian E, Monavari SH, Irajian GR, Jalali Nodoshan MR, Roudsari RV, Yahyapour Y. Evaluation of human papillomavirus infections in prostatic disease: a cross-sectional study in Iran. Asian Pac J Cancer Prev. 2013;14(5):3305-8. [PubMed: 23803120].
  • 3. Mokhtari M, Taghizadeh F, Hani M. Is prostatic adenocarcinoma in a relationship with Human Papilloma Virus in Isfahan -Iran. J Res Med Sci. 2013;18(8):707-10. [PubMed: 24379849].
  • 4. Abreu AL, Souza RP, Gimenes F, Consolaro ME. A review of methods for detect human Papillomavirus infection. Virol J. 2012;9:262. doi: 10.1186/1743-422X-9-262. [PubMed: 23131123].
  • 5. Yang L, Xie S, Feng X, Chen Y, Zheng T, Dai M, et al. Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis. Sci Rep. 2015;5:14667. doi: 10.1038/srep14667. [PubMed: 26441160].
  • 6. Jalilvand S, Shoja Z, Hamkar R. Human papillomavirus burden in different cancers in Iran: a systematic assessment. Asian Pac J Cancer Prev. 2014;15(17):7029-35. [PubMed: 25227786].
  • 7. Zandi K, Eghbali SS, Hamkar R, Ahmadi S, Ramedani E, Deilami I, et al. Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009. Virol J. 2010;7:65. doi: 10.1186/1743-422X-7-65. [PubMed: 20302680].
  • 8. Mohamadian Roshan N, Jafarian A, Ayatollahi H, Ghazvini K, Tabatabaee SA. Correlation of laryngeal squamous cell carcinoma and infections with either HHV-8 or HPV-16/18. Pathol Res Pract. 2014;210(4):205-9. doi: 10.1016/j.prp.2013.12.001. [PubMed: 24417904].
  • 9. Gheit T, Tommasino M. Detection of high-risk mucosal human papillomavirus DNA in human specimens by a novel and sensitive multiplex PCR method combined with DNA microarray. Methods Mol Biol. 2011;665:195-212. doi: 10.1007/978-1-60761-817-1_12. [PubMed: 21116803].
  • 10. Pakzad R, Rafiemanesh H, Ghoncheh M, Sarmad A, Salehiniya H, Hosseini S, et al. Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics. Asian Pac J Cancer Prev. 2016;17(2):839-43. [PubMed: 26925689].
  • 11. Lin Y, Mao Q, Zheng X, Yang K, Chen H, Zhou C, et al. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis. Ir J Med Sci. 2011;180(2):497-503. doi: 10.1007/s11845-011-0692-6. [PubMed: 21400096].
  • 12. Taylor ML, Mainous A3, Wells BJ. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med. 2005;37(7):506-12. [PubMed: 15988645].
  • 13. Groom HC, Warren AY, Neal DE, Bishop KN. No evidence for infection of UK prostate cancer patients with XMRV, BK virus, Trichomonas vaginalis or human papilloma viruses. PLoS One. 2012;7(3). e34221. doi: 10.1371/journal.pone.0034221. [PubMed: 22470540].
  • 14. Aghakhani A, Hamkar R, Parvin M, Ghavami N, Nadri M, Pakfetrat A, et al. The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis. 2011;43(1):64-9. doi: 10.3109/00365548.2010.502904. [PubMed: 20662618].
  • 15. Whitaker NJ, Glenn WK, Sahrudin A, Orde MM, Delprado W, Lawson JS. Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. Prostate. 2013;73(3):236-41. doi: 10.1002/pros.22562. [PubMed: 22851253].
  • 16. Pournourali M, Tarang AR, Yousefi M. The association between 1349T>G polymorphism of ApE1 gene and the risk of prostate cancer in northern Iran. Cell Mol Biol (Noisy-le-grand). 2015;61(4):21-4. [PubMed: 26255264].
  • 17. Khodabandehloo M, Hosseini W, Rahmani MR, Rezaee MA, Hakhamaneshi MS, Nikkhoo B, et al. No detection of xenotropic murine leukemia virus-related viruses in prostate cancer in Sanandaj, west of Iran. Asian Pac J Cancer Prev. 2013;14(11):6929-33. [PubMed: 24377628].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments